HCW Biologics (HCWB) Enterprise Value (2020 - 2025)
Historic Enterprise Value for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to -$1.1 million.
- HCW Biologics' Enterprise Value fell 969.09% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 969.09%. This contributed to the annual value of -$4.7 million for FY2024, which is 3002.62% down from last year.
- Latest data reveals that HCW Biologics reported Enterprise Value of -$1.1 million as of Q3 2025, which was down 969.09% from -$2.4 million recorded in Q2 2025.
- Over the past 5 years, HCW Biologics' Enterprise Value peaked at $27.0 million during Q2 2021, and registered a low of -$73.8 million during Q3 2021.
- Over the past 5 years, HCW Biologics' median Enterprise Value value was -$7.9 million (recorded in 2023), while the average stood at -$22.3 million.
- In the last 5 years, HCW Biologics' Enterprise Value tumbled by 103810.57% in 2021 and then skyrocketed by 9544.43% in 2024.
- Over the past 5 years, HCW Biologics' Enterprise Value (Quarter) stood at -$69.4 million in 2021, then skyrocketed by 43.9% to -$38.9 million in 2022, then skyrocketed by 90.77% to -$3.6 million in 2023, then crashed by 30.03% to -$4.7 million in 2024, then skyrocketed by 76.53% to -$1.1 million in 2025.
- Its Enterprise Value was -$1.1 million in Q3 2025, compared to -$2.4 million in Q2 2025 and -$1.1 million in Q1 2025.